Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000325436 | SCV000341259 | uncertain significance | not provided | 2016-04-14 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000686882 | SCV000814422 | likely benign | Glycogen storage disease type III | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000686882 | SCV002055446 | uncertain significance | Glycogen storage disease type III | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000686882 | SCV002783796 | uncertain significance | Glycogen storage disease type III | 2022-02-02 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV000325436 | SCV004227878 | uncertain significance | not provided | 2022-05-25 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000686882 | SCV001456551 | uncertain significance | Glycogen storage disease type III | 2020-09-16 | no assertion criteria provided | clinical testing |